Improved drug access and innovation needed, Canadian trade group says

18 July 2016
canada-flag-big

Ensuring better access to drugs and improved health care innovation should be top of the agenda at an annual meeting of Canada's Premiers this week, according to industry group the Canadian Pharmacists Association (CPhA).

The meeting takes place to discuss issues that have an impact on the lives of all Canadians, and CPhA chairman Alistair Bursey is in no doubt about what he sees as the big topic.

“With Health Accord negotiations approaching, CPhA believes that health care belongs at the top of the Premiers' agenda this week,” he said, referencing the agreement on cash levels for health care agreed between the federal government and provinces or territories. "Improved drug access and health care innovation are priority issues we will be raising in connection with the meetings,” Mr Bursey added.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Today's issue

Company Spotlight





More Features in Pharmaceutical